Lip-Safe Ingredient Compliance: Ingestion Risk & Permitted Colorant List by Market

Overview #

Lip products sit in a regulatory category that most brand owners don’t fully appreciate until their first compliance rejection. Unlike rinse-off or leave-on skin products, lip formulations are partially ingested — the FDA estimates average daily lip product ingestion at around 24 mg/day for lipstick users, and some studies put habitual users closer to 87 mg/day. That changes everything: colorant approvals, heavy metal limits, preservative choices, and even fragrance restrictions all shift when ingestion is on the table. We work through this with brand partners constantly, and the single biggest source of project delays we see is a colorant list that was built for skincare, not lip use.

Why Ingestion Risk Rewrites Your Ingredient List #

The core issue is that “cosmetic grade” does not automatically mean “lip safe.” A colorant can be fully approved for eye area use and still be prohibited in lip products in the EU. This isn’t a technicality — it reflects a genuine difference in exposure route and daily dose calculation.

On our formulation side, we run a three-market check on every lip brief before we touch the bench: EU Cosmetics Regulation 1223/2009, FDA Cosmetics Guidelines, and NMPA Cosmetic Regulation. These three frameworks don’t agree on much when it comes to lip colorants, and that’s the problem.

Take D&C Red No. 36. It’s permitted in the US for lip use at up to 3% but has no corresponding EU listing in Annex IV for lip products. CI 12085, which is essentially the same pigment family, sits in a different approval status depending on whether you’re reading the EU annex or the FDA’s color additive regulations. We’ve had batches fully formulated and stability-tested before a brand realized their hero red shade wasn’t EU-compliant. That’s an expensive lesson.

Heavy metals are the other ingestion-driven concern. The EU sets a lead limit of 10 ppm in finished cosmetics under the general safety obligation, and the FDA has issued guidance recommending lead levels in lip products not exceed 10 ppm as well — though this is guidance, not a hard regulatory limit in the US. NMPA follows GB 7916 limits. The practical issue: some natural mineral pigments, particularly iron oxides from lower-grade suppliers, come in with lead at 8–12 ppm before any blending. We now require certificates of analysis with ICP-MS heavy metal data from all pigment suppliers before we approve them for lip use. We rejected our first two iron oxide vendors on this basis alone.

Permitted Colorant Frameworks: EU vs. US vs. NMPA #

This is where most projects actually stall. The three major markets use fundamentally different approval architectures.

The EU operates a positive list system under Annex IV of Regulation 1223/2009. A colorant must be explicitly listed, and the listing specifies which product types it’s approved for — including whether lip use is permitted. There are currently around 157 colorants listed in Annex IV, but not all carry lip authorization. The SCCS Scientific Opinion process is the pathway for new colorant approvals, and it’s slow — typically 3–5 years from submission to listing.

The FDA uses a different model. Color additives for cosmetics are regulated under 21 CFR Parts 73, 74, and 82. Some require batch certification (FD&C colors), others are exempt. For lip products specifically, the FDA distinguishes between “lips” and “area of eye” as separate use categories. D&C colors permitted for lip use are explicitly called out. The practical difference from EU: the US list is somewhat more permissive for certain synthetic organics, but more restrictive on a few lakes and pigments that the EU allows.

NMPA governs colorants through the Catalogue of Cosmetic Ingredients (INCI catalogue) and specific positive lists for color additives. Post-2021 regulatory reform, lip products in China are classified as “ordinary cosmetics” unless they carry functional claims, but the colorant positive list still applies strictly. Cross-referencing all three simultaneously is genuinely tedious work — we maintain an internal tri-market colorant matrix that we update quarterly.

A few things worth noting about this table. First, it’s a snapshot — these lists update, and we’ve seen NMPA make mid-year amendments that invalidate formulations already in stability testing. Second, “permitted” doesn’t mean unrestricted. Carmine, for example, is permitted in all three markets but requires allergen declaration in the EU under Annex III. Third, the CI 12085 situation in China is genuinely ambiguous right now. We tell brand partners to treat it as restricted until the next catalogue revision clarifies.

Clinical Evidence on Lip-Active Ingredients #

This is where the article angle gets interesting, because most lip “actives” have thinner clinical backing than their skincare equivalents. Ingestion risk limits what you can use at meaningful concentrations, and that constrains the evidence base. Still, there are three actives where we have enough data to make formulation decisions with confidence.

Hyaluronic Acid (HA) in Lip Plumping

The most cited study we reference internally is a randomized, double-blind, vehicle-controlled trial (n=40, 8 weeks, twice-daily application) that measured lip volume via 3D imaging and hydration via corneometry. The HA group showed a 14.7% increase in lip volume and a 22% improvement in surface hydration versus baseline. The vehicle control showed 3.1% volume change — likely mechanical effect from application. What this study doesn’t tell you is the molecular weight story. High-MW HA (>1,000 kDa) sits on the surface and provides immediate plumping through film formation. Low-MW HA (<50 kDa) penetrates the stratum corneum but raises more questions about systemic absorption via ingestion — questions the clinical literature hasn’t fully answered. We’re still not convinced the low-MW lip plumping claims are as clean from a safety substantiation standpoint as suppliers present them.

Peptides for Lip Volume and Line Reduction

Palmitoyl tripeptide-38 has the most usable data for lip applications. One split-face, double-blind study (n=33, 12 weeks) measured perioral line depth via optical profilometry. At 4 ppm concentration, the treated side showed a 17% reduction in mean wrinkle depth versus the untreated side. The control side showed 2% reduction. Honestly, 17% is a real but modest effect — enough to support a “visibly reduces lip lines” claim with appropriate qualification, not enough to support “fills wrinkles.” We almost always push back when brands want to use this data to justify stronger claims. The other issue: palmitoyl peptides at effective concentrations add meaningful cost. At 4 ppm in a 5g lip treatment, the peptide alone can represent 15–20% of raw material cost.

Vitamin E (Tocopherol) as Lip Conditioning Active

Tocopherol is the one lip active where the ingestion question actually works in your favor — it’s a recognized nutrient, and the safety profile at cosmetic use levels is well-established. A controlled study (n=28, 4 weeks, single-blind) measuring TEWL on lip tissue showed a 31% reduction in transepidermal water loss with a 1% tocopherol formulation versus petrolatum control (18% reduction). The practical formulation note: tocopherol oxidizes. In a lip balm with high wax content and limited antioxidant support, we see visible yellowing and rancid odor development by week 10–12 at 40°C stability. We use tocopherol acetate in most lip bases for this reason — it’s more stable, though technically it requires enzymatic conversion to active tocopherol on the skin surface. Whether that conversion happens efficiently on lip tissue is a question we haven’t fully resolved.

For a deeper look at how we handle antioxidant stability in leave-on formats, see our Vitamin C & Antioxidant Systems technical notes.

Evidence Strength Comparison: Lip Actives #

The honest read on this table: most lip actives sit at moderate evidence at best. The category hasn’t attracted the same clinical investment as anti-aging serums or SPF products. Brand partners sometimes push us to make claims that the evidence simply doesn’t support, and we push back. A “clinically proven to plump” claim in the EU requires substantiation that most supplier dossiers don’t actually provide.

Where Most Brands Get This Wrong #

The most common failure mode we see isn’t a colorant compliance issue — it’s a preservative system that was designed for a water-based skincare product and then carried over into a lip gloss or tinted balm without adjustment.

Anhydrous lip products (waxes, oils, no free water) technically don’t need preservation in the traditional sense. But the moment you add a water phase — even a small humectant blend at 5–8% — you create a microbiological risk that the wax matrix alone won’t control. We’ve seen gram-positive contamination in lip glosses with water activity above 0.75 that passed initial challenge testing but failed at the 6-month mark under real-world storage conditions. The preservative system was adequate for the lab batch. At 150 kg production scale, the mixing sequence changed slightly, the water phase wasn’t held at temperature long enough, and the preservative distribution was uneven. That’s a scale-up failure, not a formulation failure — but the brand doesn’t always see the distinction.

The other issue is fragrance. Lip products have a direct ingestion route, and several fragrance materials restricted under EU Cosmetics Regulation 1223/2009 Annex III carry lower permitted concentrations for “products applied to mucous membranes” than for general leave-on use. Coumarin, for example, is restricted to 0.5% in leave-on products but has additional considerations for lip use given ingestion. We flag this on every fragrance brief. Most fragrance houses don’t automatically flag it for you.

For brand partners working on barrier-focused lip treatments, our Barrier Repair & Sensitive Skin formulation notes cover the occlusive and emollient selection logic we use across lip and perioral applications.

Claim Substantiation Guidance by Market #

EU: Claims must be substantiated under the Common Criteria established by Regulation (EC) No 655/2013. For lip products, “plumping,” “volumizing,” and “anti-aging” claims all require either clinical data (with methodology disclosed) or a robust in-vitro/ex-vivo dossier. The SCCS Scientific Opinion framework doesn’t directly govern claims, but SCCS opinions on ingredient safety are frequently cited in claim substantiation files. Vague claims like “nourishing” or “moisturizing” are lower risk but still require some substantiation. Quantified claims (“reduces lip lines by X%”) require the study to be conducted on the finished product, not just the active ingredient.

US (FDA): The FDA’s primary concern with lip products is the drug/cosmetic boundary. Any claim that implies a physiological change — “increases collagen,” “stimulates cell renewal,” “repairs lip tissue” — risks drug classification. “Moisturizes,” “conditions,” “softens” are cosmetic territory. “Plumps” sits in a grey zone that the FDA hasn’t formally addressed, but we advise caution. The FDA Cosmetics Guidelines don’t require pre-market approval for cosmetics, but substantiation is expected and the FTC governs advertising claims independently.

NMPA (China): Post-2021, lip products are ordinary cosmetics unless they carry SPF, whitening, or anti-hair-loss claims. Ordinary cosmetics don’t require pre-market registration — only filing. But the NMPA Cosmetic Regulation requires a safety assessment and efficacy claim substantiation file. For lip products specifically, any claim touching on “repair,” “anti-aging,” or “brightening” will be scrutinized. We recommend keeping lip product claims conservative for the China market unless you have a full clinical dossier ready at filing.

The practical reality: a claim that’s substantiated for EU use is usually substantiated for US use, but not always for NMPA. China’s efficacy substantiation requirements have specific methodological preferences — corneometry for hydration, image analysis for texture — that don’t always align with the study designs used in EU dossiers. We’ve had to commission supplementary testing specifically for NMPA filing on three separate lip product projects.

Formulation Notes for Brand Partners #

When a brand comes to us with a lip brief, the first questions we ask are: What market are you launching in first? What’s the on-pack claim hierarchy? And — critically — do you have a colorant palette already, or are we building from scratch?

If you’re targeting all three markets simultaneously, we build the colorant list from the intersection of EU Annex IV (lip-approved), FDA 21 CFR (lip-permitted), and NMPA catalogue — which is a smaller set than most brands expect. You lose some shades. That’s the trade-off for a globally compliant formula.

For actives, we typically recommend keeping the functional story simple for lip: one primary moisturizing/conditioning active with solid safety data, one optional performance active (peptide or HA) if the brand positioning supports it, and a clean antioxidant system to protect the base. Trying to stack five actives in a lip product creates both a cost problem and a safety assessment burden that rarely pays off commercially.

Packaging matters more than most brands budget for. Airless pump formats for lip serums add $0.40–$0.80 per unit at MOQ 1,000 — most indie brands absorb that reluctantly. Standard doe-foot applicators are fine for glosses but create contamination risk in water-containing formulas. We almost always recommend a preservative efficacy test (PET) per ISO 11930 on the final packaging configuration, not just the formula in a jar.

Timeline expectation: a tri-market compliant lip color with custom shade development runs 16–20 weeks from brief to stability-complete sample. Brands that come in expecting 8 weeks usually haven’t accounted for colorant compliance review.

Frequently Asked Questions #

Q: Can we use carmine in our lip products for the EU and US markets?

Yes, carmine (CI 75470) is permitted for lip use in both markets. In the EU, it requires an allergen declaration — “contains carmine” or “may cause allergic reactions” — under Annex III. In the US, FDA requires “carmine” or “cochineal extract” to be declared by name on the label per 21 CFR 73.100. Budget for the labeling requirement from day one; we’ve seen brands miss this and have to reprint packaging runs.

Q: We want to claim “clinically proven to plump lips” — what do we actually need?

For EU substantiation, you need a clinical study conducted on the finished product, not just the active. Minimum n=30 is the practical threshold most assessors expect, with a validated measurement method (3D imaging or optical profilometry, not self-assessment alone). A 4-week study is borderline; 8–12 weeks is more defensible. Without that, you’re looking at a qualified claim — “visibly plumps” with an asterisk — which is a different brief entirely.

Q: What’s the lead limit we need to hit for lip products across all three markets?

The EU general safety obligation and FDA guidance both point to 10 ppm as the practical ceiling for lead in lip products. NMPA follows GB 7916, which sets lead at ≤10 mg/kg (equivalent to 10 ppm) for lip products. In practice, we target ≤5 ppm in our finished product specs to give headroom for batch-to-batch variation in pigment lots. Any supplier who can’t consistently deliver iron oxides below 8 ppm on ICP-MS doesn’t stay on our approved list.

Q: Can we use the same preservative system from our face cream in a lip gloss?

Probably not without adjustment. Phenoxyethanol at 1% is fine for a face cream but sits at the upper limit of what we’d use in a lip product given ingestion exposure. We typically run lip formulas at 0.5–0.8% phenoxyethanol maximum, paired with ethylhexylglycerin or caprylyl glycol for boosting efficacy at lower concentrations. If your gloss is truly anhydrous, you may not need preservation at all — but confirm water activity before making that call.

Q: We’re seeing “clean beauty” lip products with no synthetic colorants — is natural pigment compliance simpler?

Honestly, no. Natural colorants like beta-carotene, annatto, and chlorophyllin-copper complex all have their own approval status variations across markets. Beta-carotene is permitted in the EU under Annex IV but has concentration limits. Annatto (CI 75120) has a more complicated status. And natural pigments tend to have worse heavy metal profiles than synthetic alternatives — more variability in lead and arsenic content depending on agricultural source. The “clean” positioning doesn’t simplify the compliance work. It often adds to it.

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.